About Us

Founded by leading researchers and experts in immunology, pharmaceutical biotechnology, and tech transfer, SingleStrand Biotech harnesses over 20 years of scientific expertise to create innovative and effective therapeutic solutions. Backed by experienced advisors and investors, our mission is to bring accessible, targeted, and safer treatments to patients worldwide.

Who We Are

Who We Are

SingleStrand Biotech is a biotechnology company pioneering the development of synthetic single-stranded oligonucleotide (ODN) drugs that modulate the immune system and promote tissue regeneration. Our focus is on delivering next-generation therapies for chronic inflammatory diseases—starting with Crohn’s Disease—through innovative, precise, and long-lasting solutions.

OUR DNA

The Single Strand Biotech logo combines two key symbols: a single DNA strand and a sandwatch.  The DNA  strand reflects our focus on single-stranded oligonucleotide therapies, while the sandwatch hourglass represents our mission to extend and improve patients’ lives. Together, they capture the essence of life, time, and innovation in biotechnology.

VISION & MISSION

To become a global leader in synthetic immunomodulatory therapies that redefine the standard of care for chronic inflammatory and autoimmune diseases.

Our mission is to develop safe, effective, and long-lasting synthetic oligonucleotide drugs that restore immune homeostasis and tissue health, improving quality of life for millions of patients with inflammatory diseases.

Latest News